Frequency Therapeutics
PublicFrequency Therapeutics is now publicly traded
The data on this page reflects Frequency Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
PIPE
Apr 18, 2024
Total Funding Raised
$394.5M
Company Overview
Korro Bio is a biopharmaceutical company focused on discovering, developing, and commercializing innovative genetic medicines that utilize RNA editing to treat both rare and common diseases with enhanced precision and flexibility.
Sector
Biotech
AI Layer
Non-AI
Keywords
RNA editing genetic medicineOligonucleotide Promoted Editing of RNA (OPERA) platformADAR-mediated RNA editingSingle-base RNA editingAlpha-1 Antitrypsin Deficiency (AATD) therapyTransient RNA editingOligonucleotide-based therapeuticsTherapeutics for rare genetic diseasesLiver disease genetic medicineCentral nervous system (CNS) genetic medicineBiopharma R&D collaborationClinical-stage biopharmaceutical companyCardiometabolic disease therapeutics
Frequency Therapeutics Comparables
Compare Frequency Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AIRNA | 90% | |
| Serapha Bio | 81% | |
| AccurEdit Therapeutics | 76% | |
Frequency Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| PIPE | Apr 18, 2024 | ||||
| Private Placement | Nov 3, 2023 | ||||
| Series B | Jan 5, 2022 | ||||
| Series A | Sep 10, 2020 | ||||
| Seed | Oct 7, 2019 |
Key People
Founding team and executive leadership
Frequency Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sixty Degree Capital | Series B, Private Placement |
| MP Healthcare Venture Management | Series A, Series B, Private Placement |
| New Enterprise Associates (NEA) | Seed, Series A, PIPE, Series B, Private Placement |
| Eventide Funds | Private Placement, Series B |
| Wu Capital | Series B, Series A |
| Fidelity Management & Research Company | Series B |
| Blue Owl Capital | PIPE |
Frequency Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersCambridge, Massachusetts
Employee Range76
Year Founded2018
Last FundingApr 18, 2024
See something wrong or outdated?